|Another example of "interesting" reporting. |
"Orbimed Advisors LLC trimmed its holdings in shares of Immunomedics, Inc. (NASDAQ:IMMU) by 71.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 9,996,816 shares of the biopharmaceutical company’s stock after selling 24,932,142 shares during the period."
Which is kind of hard to reconcile with them increasing their holdings from 4,928,958 to 9,996,816 in their Sep 30 filing.
Gotta assume this is just bad reporting. Where in the world they get 24M shares sold I can't imagine.